Skip to main content
. 2003 Mar;131(3):528–535. doi: 10.1046/j.1365-2249.2003.02083.x

Table 4b.

Correlation between plasma PR3 and markers of leucocyte activation

Vasc-pat CC (95% CI) DC CC (95% CI) HBD CC (95% CI)
PR3 versus NGAL 0·04 (− 0·22–0·29) n.s. 0·26 (− 0·03–0·51) n.s. 0·10 (− 0·28–0·46) n.s.
PR3 versus NGAL/C 0·11 (− 0·15–0·36) n.s. 0·30 (0·01–0·55) s. −0·03 (− 0·42–0·37) n.s.
PR3 versus sTNFr1 −0·07 (− 0·32–0·19) n.s. 0·08 (− 0·22–0·36) n.s. 0·15 (− 0·24–0·50) n.s.
PR3 versus sTNFr1/C −0·04 (− 0·29–0·23) n.s. −0·10 (− 0·38–0·19) n.s. −0·12 (− 0·5–0·30) n.s.

Vasc-pat = all vasculitis patients. DC = disease controls. HBD = healthy blood donors. CC = correlation coefficient. 95% CI = 95% confidence interval. NGAL/C = NGAL divided by cystatin C. sTNFr1/C = sTNFr1 divided by cystatin C. n.s. = non-significant, s. = significant.